In this study, analysis of PD-L1 showed an increase in ORR between PD-L1 positive versus PD-L1 negative tumors (P = 0.23) when both tumor and stromal cells were used to score PD-L1 [65]. This evidence concerns the gene CD274 and neoplasm.